Use of Drawing Lithography-Fabricated Polyglycolic Acid Microneedles for Transdermal Delivery of Itraconazole to a Human Basal Cell Carcinoma Model Regenerated on Mice
- 304 Downloads
Itraconazole is a triazole agent that is routinely used for treatment of nail infections and other fungal infections. Recent studies indicate that itraconazole can also inhibit the growth of basal cell carcinoma (BCC) through suppression of the Sonic Hedgehog (SHH) signaling pathway. In this study, polyglycolic acid microneedle arrays and stainless steel microneedle arrays were used for transdermal delivery of itraconazole to a human BCC model which was regenerated on mice. One-by-four arrays of 642-μm-long polyglycolic acid microneedles with sharp tips were prepared using injection molding and drawing lithography. Arrays of 85 stainless steel 800-μm-tall microneedles attached to syringes were obtained for comparison purposes. Skin grafts containing devitalized split-thickness human dermis that had been seeded with human keratinocytes transduced to express human SHH protein were sutured to the skin of immunodeficient mice. Mice with this human BCC model were treated daily for 2 weeks with itraconazole dissolved in 60% dimethylsulfoxane and 40% polyethylene glycol-400 solution; transdermal administration of the itraconazole solution was facilitated by either four 1 × 4 polyglycolic acid microneedle arrays or stainless steel microneedle arrays. The epidermal tissues treated with polyglycolic acid microneedles or stainless steel microneedles were markedly thinner than that of the control (untreated) graft tissue. These preliminary results indicate that microneedles may be used to facilitate transdermal delivery of itraconazole for localized treatment of BCC.
KeywordsItraconazole Basal Cell Carcinoma National Comprehensive Cancer Network Imiquimod Polyglycolic Acid
The authors would like to thank Gigi Davidson, Director of Clinical Pharmacy Services at the NC State College of Veterinary Medicine, and her staff for their efforts to develop and prepare the itraconazole formulation. We thank Paul Khavari and Anthony Oro of Stanford University for providing the SHH expression construct.
- 1.“Basal cell carcinoma” (The Skin Cancer Foundation, 2015), http://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma. Accessed 4 January 2016.
- 6.R. S. Bader, L. Santacroce, A. S. Kennedy, “Basal Cell Carcinoma Treatment & Management” (Medscape, 2016), http://emedicine.medscape.com/article/276624-treatment. Accessed 4 Jan 2016.
- 10.“Fluorouracil Cream” (Drugs.com, 2016), http://www.drugs.com/pro/fluorouracil-cream.html. Accessed 4 Jan 2016.
- 11.“Aldara” (Drugs.com, 2016), http://www.drugs.com/pro/aldara.html. Accessed 4 Jan 2016.
- 12.“Itraconazole” (Merck Sharp & Dohme Corp., 2016), http://www.merckmanuals.com/professional/lexicomp/itraconazole.html. Accessed 4 Jan 2016.
- 13.“Itraconazole”, (Drugs.com, 2016). http://www.drugs.com/pro/itraconazole.html. Accessed 4 Jan 2016.
- 14.N. Mulcahy, “Common Antifungal Drug Works in Basal Cell Carcinoma” (Medscape, 2016) http://www.medscape.com/viewarticle/820444. Accessed 4 Jan 2016.
- 18.J. Montoya, M. Molgo, P. Uribe, and S. Gonzalez, J. Am. Acad. Dermatol. 66, AB155 (2012).Google Scholar
- 20.D.J. Kim, J. Kim, K. Spaunhurst, J. Montoya, R. Khodosh, T. Fu, A. Gilliam, M. Molgo, P.A. Beachy, and J.Y. Tang, J. Invest. Dermatol. 582, S101 (2014).Google Scholar
- 21.“Sporanox & Lamisil Public Health Advisory issued.” (Medscape 2016), http://www.medscape.com/viewarticle/446823. Accessed 4 Jan 2016.
- 23.H. Hong, J. Sun, and W. Cai, Clin. Cosmet. Investig. Dermatol. 1, 1 (2008).Google Scholar
- 24.“Itraconazole” (Selleck Chemicals, 2016), http://www.selleckchem.com/products/Itraconazole(Sporanox).html. Accessed 4 Jan 2016.
- 34.V. V. Yuzhakov, Microneedle array, patch, and applicator for transdermal drug delivery, US Patent 7658728 B2, February 9, 2010.Google Scholar
- 35.V. V. Yuzhakov, Tissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection, US Patent 7785301 B2, August 31, 2010.Google Scholar
- 36.V. V. Yuzhakov, Method of making microneedle array and device for applying microneedle array to skin, US Patent US8414548 B2, April 9, 2013.Google Scholar